These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6260509)

  • 1. Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells.
    Black PL; Vitetta ES; Forman J; Kang CY; May RD; Uhr JW
    Eur J Immunol; 1981 Jan; 11(1):48-55. PubMed ID: 6260509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
    Ciavarra RP; Kang CY; Forman J
    J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
    [No Abstract]   [Full Text] [Related]  

  • 4. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells.
    Zinkernagel RM; Althage A; Holland J
    J Immunol; 1978 Aug; 121(2):744-8. PubMed ID: 210232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
    Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
    J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactive anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes recognize the major surface glycoprotein.
    Hale AH; Ruebush MJ; Lefrançois L
    Eur J Immunol; 1981 May; 11(5):434-6. PubMed ID: 6266837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
    Lefrancois L; Lyles DS
    J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of low infectivity vesicular stomatitis virus particles from tunicamycin-treated cells.
    Maheshwari RK; Singh VK; Husain MM; Friedman RM; Mohanty SB
    J Exp Pathol; 1985; 2(3):149-63. PubMed ID: 3023584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vesicular stomatitis virus major glycoprotein in determining the specificity of virus-specific and H-2-restricted cytolytic T cells.
    Sethi KK; Brandis H
    Eur J Immunol; 1980 Apr; 10(4):268-72. PubMed ID: 6249612
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glycosylation prevents H-2K and D antigen expression on SV40 virus-transformed cells.
    Swaminathan S; Gooding LR
    Eur J Immunol; 1983 Apr; 13(4):335-40. PubMed ID: 6303796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
    Sheil JM; Bevan MJ; Lefrancois L
    J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of H-2 and viral antigens and resistance to the antitumor lysis of tunicamycin-treated MBL-2 lymphoma cells.
    Colombo MP; Pierotti MA; Ballinari D; Parmiani G
    Immunobiology; 1983 Aug; 165(2):186-99. PubMed ID: 6605298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation and specificity of anti-vesicular stomatitis virus-specific cytotoxic T lymphocytes.
    Ruebush MJ; Hale AH; Lefrancois L; Harris DT; Burgess DE
    J Immunol; 1981 May; 126(5):2053-9. PubMed ID: 6260862
    [No Abstract]   [Full Text] [Related]  

  • 19. Limitation of VSV infection by the host's response to VSV-associated cellular antigens.
    Hecht TT; Paul WE
    J Immunol; 1982 Oct; 129(4):1736-41. PubMed ID: 6180021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.